Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Fixed-duration glofitamab induced high CR rates in heavily pretreated patients with R/R MCL; the safety profile was manageable with appropriate support.
Authors
- Jan Maciej Zaucha (ORCID: https://orcid.org/0000-0002-0986-8936)
- Ben E. Byrne (ORCID: https://orcid.org/0000-0002-2183-8166)
- Tomasz Wróbel (ORCID: https://orcid.org/0000-0002-6612-3535)
- Carmelo Carlo‐Stella (ORCID: https://orcid.org/0000-0003-3144-0124)
- Franck Morschhauser (ORCID: https://orcid.org/0000-0002-3714-9824)
- Naseer Qayum
- Emmanuel Bachy (ORCID: https://orcid.org/0000-0003-2694-7510)
- Michael Crump (ORCID: https://orcid.org/0000-0002-2230-8538)
- Tycel Phillips (ORCID: https://orcid.org/0000-0003-2143-9672)
- Linda Lundberg
- James Relf
- Nancy L. Bartlett (ORCID: https://orcid.org/0000-0001-8470-394X)
- David Carlile (ORCID: https://orcid.org/0009-0002-2379-3253)
- Marek Trněný (ORCID: https://orcid.org/0000-0002-6952-6073)
- Michael John Dickinson (ORCID: https://orcid.org/0000-0002-1492-5966)
- Audrey Filézac de L’Etang
- Kathryn Humphrey
- Fritz Offner (ORCID: https://orcid.org/0000-0003-4690-3603)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Roche (Switzerland) (CH)
- City Of Hope National Medical Center (US)
- The Royal Melbourne Hospital (AU)
- Humanitas University (IT)
- The University of Melbourne (AU)
- Washington University in St. Louis (US)
- Charles University (CZ)
- University of Michigan (US)
- Universitair Ziekenhuis Leuven (BE)
- Peter MacCallum Cancer Centre (AU)
- Princess Margaret Cancer Centre (CA)
- Centre Hospitalier Universitaire de Lille (FR)
- Wroclaw Medical University (PL)
- Hospices Civils de Lyon (FR)
- Roche (United Kingdom) (GB)
- Universitair Ziekenhuis Brussel (BE)
- IRCCS Humanitas Research Hospital (IT)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1200/jco.23.02470
- Citations
- 46
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 19.55
Funders
- F. Hoffmann-La Roche